Skip to content
10-Q

Quarterly Report

TVARDI THERAPEUTICS, INC. TVRD

0001104659-25-111289

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 9.38M sh
Shares Diluted Q3 2025 · Sep 30, 2025 9.38M sh
Shares Diluted Q3 2025 · Sep 30, 2025 7.24M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 2.57M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 2.57M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$17.81M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$13.47M
Short Term Investments Q3 2025 · Sep 30, 2025 $15.04M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $21.42M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $31.61M
Stockholders Equity Q3 2025 · Sep 30, 2025 $27.87M
Stockholders Equity Q3 2025 · Jun 30, 2025 $32.93M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$100.63M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$91.13M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 −$78.5M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 −$73.07M
Stockholders Equity restated Q3 2025 · Mar 31, 2024 −$66.17M
Stockholders Equity restated Q3 2025 · Dec 31, 2023 −$62.06M
Current Liabilities Q3 2025 · Sep 30, 2025 $11.04M
Current Liabilities Q3 2025 · Dec 31, 2024 $10.37M
Total Liabilities Q3 2025 · Sep 30, 2025 $11.16M
Total Liabilities Q3 2025 · Dec 31, 2024 $40.83M
Current Assets Q3 2025 · Sep 30, 2025 $38.44M
Current Assets Q3 2025 · Dec 31, 2024 $31.69M
Total Assets Q3 2025 · Sep 30, 2025 $39.02M
Total Assets Q3 2025 · Dec 31, 2024 $35.2M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.59
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.50
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$2.14
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$6.48
Eps Basic Q3 2025 · Sep 30, 2025 −$0.59
Eps Basic Q3 2025 · Sep 30, 2025 −$1.62
Eps Basic restated Q3 2025 · Sep 30, 2024 −$2.14
Eps Basic restated Q3 2025 · Sep 30, 2024 −$6.48
Sga Expense Q3 2025 · Sep 30, 2025 $2.34M
Sga Expense Q3 2025 · Sep 30, 2025 $6.64M
Sga Expense restated Q3 2025 · Sep 30, 2024 $881K
Sga Expense restated Q3 2025 · Sep 30, 2024 $2.26M
Rd Expense Q3 2025 · Sep 30, 2025 $3.6M
Rd Expense Q3 2025 · Sep 30, 2025 $12.52M
Rd Expense restated Q3 2025 · Sep 30, 2024 $4.8M
Rd Expense restated Q3 2025 · Sep 30, 2024 $15.05M
Net Income Q3 2025 · Sep 30, 2025 −$5.53M
Net Income Q3 2025 · Sep 30, 2025 −$10.94M
Net Income Q3 2025 · Jun 30, 2025 $4.17M
Net Income Q3 2025 · Mar 31, 2025 −$9.58M
Net Income restated Q3 2025 · Sep 30, 2024 −$5.51M
Net Income restated Q3 2025 · Sep 30, 2024 −$16.69M
Net Income restated Q3 2025 · Jun 30, 2024 −$6.98M
Net Income restated Q3 2025 · Mar 31, 2024 −$4.2M
Operating Income Q3 2025 · Sep 30, 2025 −$5.94M
Operating Income Q3 2025 · Sep 30, 2025 −$19.16M
Operating Income restated Q3 2025 · Sep 30, 2024 −$5.68M
Operating Income restated Q3 2025 · Sep 30, 2024 −$17.31M